Skip to content

A trial to investigate the effect of acalabrutinib on skin prick test wheal size in adults with grass pollen allergy

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505783-11-00
Acronym
AC-01
Enrollment
12
Registered
2023-10-19
Start date
2023-10-26
Completion date
2024-01-31
Last updated
2023-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

grass pollen allergy

Interventions

None listed

Sponsors

Alk-Abello A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026